Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS

NCT03624244 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT03624244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03624244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Recruiting
Start date
January 23, 2019
Completion date
January 31, 2031
Enrollment
40 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

low grade endometrial stromal sarcoma